Sybil McAuley

Sybil McAuley is an Associate Professor (Research) at the School of Public Health and Preventive Medicine, Monash University. She is also an Endocrinologist and Type 1 Diabetes Clinical Lead at Alfred Health, combining academic research with clinical practice. She holds an MBBS and PhD from the University of Melbourne and is currently accepting PhD students.

• MBBS, University of Melbourne
• PhD, University of Melbourne

Her research focuses on type 1 diabetes, particularly automated insulin delivery (AID) systems, glycemic control, and the impact of lifestyle and technology on diabetes management. She investigates how interventions like activity breaks and digital health tools can improve metabolic outcomes in adults with type 1 diabetes. Her work contributes to public health and preventive medicine, with strong relevance to aging populations and chronic disease management.

The recent articles show a clear trend toward evaluating innovative diabetes technologies in real-world and clinical settings. Themes include driving safety with AID, sedentary behavior interventions, vaccination impacts, and aging with diabetes. These studies predominantly use clinical trial and observational designs, often in collaboration with national research groups such as the JDRF Closed-Loop Research Group.

No scientific awards are mentioned in the provided text.

Sybil McAuley advises PhD students and is involved in significant research collaborations, particularly in diabetes technology and clinical outcomes. Her work includes multi-center trials and policy-relevant studies, though specific grant details are not provided. She collaborates extensively with clinicians and researchers across Australia, contributing to national advancements in diabetes care.

She is involved in research networks focusing on type 1 diabetes and automated insulin delivery, collaborating with institutions and clinical teams across Australia. Her work with the JDRF Closed-Loop Research Group highlights her role in a coordinated, multidisciplinary research team advancing closed-loop insulin therapy.